Intermittent Fasting in Breast Cancer: A Systematic Review and Critical Update of Available Studies.

ABSTRACT: Breast cancer (BC) is the most-frequent malignancy amongst women, whereas obesity and excess caloric consumption increase the risk for developing the disease. The objective of this systematic review was to examine the impact of intermittent fasting (IF) on previously diagnosed BC patients, regarding quality of life (QoL) scores during chemotherapy, chemotherapy-induced toxicity, radiological response and BC recurrence, endocrine-related outcomes, as well as IF-induced adverse effects in these populations. A comprehensive search was conducted between 31 December 2010 and 31 October 2022, using the PubMed, CINAHL, Cochrane, Web of Science, and Scopus databases. Two investigators independently performed abstract screenings, full-text screenings, and data extraction, and the Mixed Method Appra

SUBMITTER: Anemoulis M 

PROVIDER: S-EPMC9920353 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature